Resistance of Targeted Therapies Excluding Antibodies for Lymphomas
In the last decade, the literature on molecular mechanisms and activated pathways in the different lymphoma categories increased exponentially, which was followed by a more diffuse and successful use of targeted therapies. In this book, expert authors revisit the most relevant aspects of these thera...
Corporate Author: | SpringerLink (Online service) |
---|---|
Other Authors: | Ferreri, Andrés J. M. (Editor, http://id.loc.gov/vocabulary/relators/edt) |
Format: | Electronic eBook |
Language: | English |
Published: |
Cham :
Springer International Publishing : Imprint: Springer,
2018.
|
Edition: | 1st ed. 2018. |
Series: | Resistance to Targeted Anti-Cancer Therapeutics,
17 |
Subjects: | |
Online Access: | Full Text via HEAL-Link |
Similar Items
-
Current Applications for Overcoming Resistance to Targeted Therapies
Published: (2019) -
Cancer Stem Cell Resistance to Targeted Therapy
Published: (2019) -
Innovations for Next-Generation Antibody-Drug Conjugates
Published: (2018) -
Targeted Therapies for Lung Cancer
Published: (2019) -
Estrogen Receptor and Breast Cancer Celebrating the 60th Anniversary of the Discovery of ER /
Published: (2019)